Takara Bio Inc. Financial Overview
Takara Bio Inc.'s market cap is currently ¥93.20B. The company's EPS TTM is ¥-44.85; its P/E ratio is -14.54; and it has a dividend yield of 2.20%. Takara Bio Inc. is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
